Atossa Therapeutics (Germany) Top Insiders
YAG2 Stock | EUR 1.15 0.04 3.60% |
Atossa Therapeutics employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Atossa Therapeutics' management performance can provide insight into the company performance.
Heather Rees Insider VP Accounting |
FCAP MD Insider CEO Chairman |
Atossa |
Atossa Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.113) % which means that it has lost $0.113 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1833) %, meaning that it generated substantial loss on money invested by shareholders. Atossa Therapeutics' management efficiency ratios could be used to measure how well Atossa Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Atossa Therapeutics Workforce Comparison
Atossa Therapeutics is rated first in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 8,574. Atossa Therapeutics adds roughly 6.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Atossa Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Atossa Therapeutics Price Series Summation is a cross summation of Atossa Therapeutics price series and its benchmark/peer.
Atossa Therapeutics Notable Stakeholders
An Atossa Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Atossa Therapeutics often face trade-offs trying to please all of them. Atossa Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Atossa Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Heather Rees | VP Accounting | Profile | |
FCAP MD | CEO Chairman | Profile | |
Delly PHR | VP HR | Profile | |
RAC MSPH | Quality Regulatory | Profile | |
Richard MD | Interim Officer | Profile | |
CPA Esq | Gen CFO | Profile |
About Atossa Therapeutics Management Performance
The success or failure of an entity such as Atossa Therapeutics often depends on how effective the management is. Atossa Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Atossa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Atossa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. ATOSSA THERAPEU operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6 people.
Atossa Therapeutics Workforce Analysis
Traditionally, organizations such as Atossa Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Atossa Therapeutics within its industry.Atossa Therapeutics Manpower Efficiency
Return on Atossa Therapeutics Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 3.4M | |
Net Loss Per Executive | 3.4M |
Complementary Tools for Atossa Stock analysis
When running Atossa Therapeutics' price analysis, check to measure Atossa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Therapeutics is operating at the current time. Most of Atossa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Atossa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Therapeutics' price. Additionally, you may evaluate how the addition of Atossa Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |